Pfizer Confirms EU Pegfilgrastim Launch Plans

Follows Formal European Commission Approval For Nyvepria Biosimilar

Red_Rocket
Pfizer has confirmed a launch window for its Nyvepria pegfilgrastim biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Archive

More from Generics Bulletin